Delivery Order SPE2DB22D1017-SPE2DB23FF9PQ

Award Date 7/7/23
Potential Completion Date 7/10/23
Potential Value $427
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred seventy-eight dollars to Amerisourcebergen Drug Corporation for the supply of one hundred tablets of the pharmaceutical product mycophenolate at five hundred milligrams per tablet. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 4 through August 7, 2023. This delivery order was issued against an existing DLA...
The Defense Logistics Agency awarded a delivery order valued at $249.20 to Amerisourcebergen Drug Corporation for the supply of 100 tablets of 500 mg mycophenolate. The contract has a firm fixed price and requires delivery to a facility in Conshohocken, Pennsylvania by August 22, 2023. Amerisourcebergen will perform as the prime contractor to fulfill the Defense Logistics Agency's requirement for this pharmaceutical product. The delivery order was issued against an existing...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $214 to Amerisourcebergen Drug Corporation for 100 tablets of the generic drug mycophenolate. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by September 21, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will supply the pharmaceutical to the DLA in support of the agency's provision of supplies and services to the U.S. military and other...
The Defense Logistics Agency awarded a $800.37 firm fixed price delivery order contract to Amerisourcebergen Drug Corp for the supply of 4561888138 MYCOPHENOLATE 500 MG TABLET 500S. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested pharmaceutical products from its facility located in Conshohocken, Pennsylvania. The contract supports the Defense Logistics Agency's mission to provide medical supplies and logistics support to the Department of Defense....
The Defense Logistics Agency awarded a $71,200 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 bottles of 500mg mycophenolate tablets. The place of performance for this single-day contract is Amerisourcebergen's facility in Conshohocken, Pennsylvania. No additional details were provided regarding the larger vehicle or program this order supports within the Defense Department. The award utilizes commercial item procedures with no set-aside designation.
The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred sixty-four dollars and six cents to Amerisourcebergen Drug Corporation for five hundred capsules of the pharmaceutical mycophenolate. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order period of performance spans July 12 through July 13, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will fulfill this...
The Defense Logistics Agency awarded a $768 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 360 mg tablets of mycophenolic acid in 120 count bottles. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania within a one day period beginning September 6, 2023. The Defense Logistics Agency routinely issues delivery orders against various pharmaceutical distribution contracts to...
The Defense Logistics Agency awarded a $207,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 capsules of 250mg mycophenolate. The order was placed under an existing Prime Vendor contract vehicle to provide pharmaceutical products and services to DLA and DoD customers. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in early September 2023. No subcontractors or set aside designations were...
Defense Logistics Agency awarded a delivery order against an unspecified contract vehicle to Amerisourcebergen Drug Corp on October 17, 2023. The $620 firm fixed price order is for 500 capsules of the generic drug mycophenolate and will be fulfilled by Amerisourcebergen Drug Corp's Conshohocken, PA facility by October 18, 2023. The prime contractor, Amerisourcebergen Drug Corp, is a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distributor. No set-aside provision was...
The Defense Logistics Agency awarded a $173,520 firm fixed price delivery order to AmerisourceBergen Drug Corporation for the supply of 500 tablets of 500 milligram mycophenolate. The order is to be fulfilled by AmerisourceBergen from its facility located in Conshohocken, Pennsylvania by August 14, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to support all military services and combatant commands worldwide. This delivery order...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB23FF9PQ
    Delivery Order

The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $427 to Amerisourcebergen Drug Corporation for the supply of 500 tablets of 500 milligram mycophenolate. The contract has a period of performance from July 7 through July 10, 2023, with performance to take place in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will serve as the prime contractor on this delivery order placed against an existing DLA pharmaceuticals contract vehicle. No subcontractors or set aside designations were identified in the award information.

Generated 12/16/23, 11:01 PM